IRRITABLE BOWEL SYNDROME, RELEVANCE OF PROBLEM AND ISSUES OF MODERN THERAPY


Cite item

Full Text

Abstract

The article discusses a functional disorder of the gastrointestinal tract - irritable bowel syndrome (IBS). The basic mechanisms of the pathogenesis of IBS, clinical manifestations are discussed; treatment approaches in accordance with the mechanisms of clinical symptoms are described. Much attention is paid to the role of modern selective myotropic spasmolytics with combined effect - calcium channel blocker pinaverium bromide (Dicetel) and sodium channels blocker mebeverine (Duspatalin) in the correction of abdominal pain, dyspeptic symptoms and other manifestations of IBS; current algorithms of diagnosis and therapy of this pathology are presented

References

  1. Saito YA, Shoenfeld P, Locke GRI. The epidemiology of irritable bowel syndrome in North America: a systemic review. Am J Gastroenterol 2002;97:1910-15.
  2. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004;20(7):31-9.
  3. Gwee KA. Irritablebowel syndrome in developing countries - a disorder of civilization or colonization? Neurogastroenterol Motil 2005;17:317-24.
  4. Longstreth GF. Definition and classification of IBS: current consensus and controversies. Gastroenterol Clin North Am 2005;34:173-87.
  5. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130(5):1377-90.
  6. Dumitrascu DL. Making a Positive Diagnosis of IBS. Pan-European Conference on Irrtable Bowel Syndrom, Vienna, December 10th, 2010.
  7. Posserud I, Stotzer PO, Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-08.
  8. Aerssens J, Camilleri M, Talloen W, et al. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008;6:194-205.
  9. Camilleri M. Mechanisms in IBS: something old, something new, something borrowe. Neurogastroenterol Motil 2005;17:311-16.
  10. Makharia GK. Abdominal pain/spasms in organic GI diseases: What do pain mean in IBD, biliary dyskinesia, and biliary colic? How to treat abdominal pain in these diseases? Pan-European Conference on Irrtable Bowel Syndrom, Vienna, December 10th, 2010.
  11. Mearin F, Perez-Oliveras M, Perell A, et al. Dyspepsia after a Salmonella gastroenteritis outbreak (one-year follow-up cohort study). Gastroenterology 2005;129:98-104.
  12. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome - a meta-analysis. Am J Gastroenterol 2006;101:1894-99.
  13. Тhabane M, Kottachchi DT, Marshall JK. Systematic review and meta-nalysis: The incidence and prognosis of post-infections irritable bowel syndrome. Falk Gastro Rev J 2007.
  14. Barbara G, Stanghellini V, DeGiorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
  15. Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007;132:26-37.
  16. Mearin F. Post-infectious IBS. Pan-European Conference on Irrtable Bowel Syndrom, Vienna, December 10th, 2010.
  17. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
  18. Ручкина И.Н., Белая О.Ф., Парфенов А.И. и др. Роль Campylobacter jejunum в патогенезе синдрома раздраженного кишечника // Российский гастроэнтерологический журнал. 2000. № 2. C. 118-19.
  19. Маев И.В., Черемушкин С.В. Психосоциальные факторы в развитии синдрома раздраженного кишечника: возможности терапии // Consilium medicum. 2006. № 7. С. 34-42.
  20. Simsek I. IBS in the whole gastrointestinal system? Pan-European Conference on Irrtable Bowel Syndrom, Vienna, December 10th, 2010.
  21. Симаненков В.И. Интерес к проблеме постинфекционного синдрома раздраженного кишечника растет // Клиническая гастроэнтерология и гепатология. Русское издание. 2008. Т. 1. № 4. С. 266-68.
  22. Nobaek S, et al. Alteration of intestinal microflora is associated with reduction in abdominal blosting and pain in patients with irritable bowel syndrome. Scand J Gastroenterol 2000;95:5:1231-38.
  23. Ивашкин В.Т., Трухманов А.С., Маев И.В. Физиологические основы моторно-эвакуаторной функции пищеварительного тракта // Российский журн. гастроэнтерол. гепатол., колопроктол. 2007. № 5. С. 4-10.
  24. Camileri M, Bueno L, de Ponti F, et al. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology. 2006;130(5):1421-34.
  25. Clarke G, Quigley EM, Cryan JF, et al. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009;15:478-89.
  26. Полуэктова В.А. Боль в животе при функциональных расстройствах кишечника // Клинические перспективы в гастроэнтерологии, гепатологии. 2001. № 2. C. 27-33.
  27. Thompson WG, Longstreth GF, Drossman DA, et al. Functional abdominal pain. The functional Gastrointestinal Disoders. Second Edition 2000; Allen Press Inc: 351.
  28. Odze RD, Goldblum JR. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas, 2nd Edition, 2009.
  29. Monnikes H. Quality of Life in Irritable Bowel Syndrome Patients. Pan-European Conference on Irrtable Bowel Syndrom, Vienna, December 10th, 2010.
  30. Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:355.
  31. Quartero A, Meineche-Schmidt V, Muris J, et al. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005;18;(2):CD003460.
  32. American College of Gastroenterology IBS Task Force. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104:S1.
  33. Буторова Л.И., Максимова И.Д. Функциональный запор: рациональные подходы к диагностике и лечению // Клинические перспективы гастроэнтерологии, гепатологии. 2004. № 2. C. 24-8.
  34. Бельмер С.В., Гасилина Т.В., Хавкин А.И., Эйберман А.С. Функциональные нарушения органов пищеварения у детей. М., 2005. C. 36.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies